Drug Trial Radar · NCT07938151
Same-Day Co-Administration of Varicella and Inactivated Hepatitis A Vaccines in Children Aged 12 to 23 Months in Shandong, China
Last checked: Nov 19, 2026Latest source record: Nov 18, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Not yet recruiting
Enrollment
35,000
Planned (sponsor's estimate)
Start
Nov 2026
Primary completion
May 30, 2028
Study completion Jul 31, 2028
Sponsor
- Lead sponsor
- Shandong UniversityAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Sinovac (Dalian) Vaccine Technology Co., Ltd.; Sinovac Biotech Co., Ltd
- First posted
- Nov 16, 2026
Design
- Study type
- Observational
- FDA-regulated drug
- No
- Who can join
- All sexes, from 12 months, up to 23 months
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The goal of this observational study is to learn whether offering same-day co-administration of the varicella (chickenpox) vaccine and the inactivated hepatitis A vaccine at routine vaccination clinics helps children in China complete both vaccines on time, and how parents feel about this service. The main questions it aims to answer are: * Do parents accept same-day administration of the two vaccines when clinics offer this option? * Are children more likely to complete both vaccines within 90 days when the same-day option is available? Participants will receive routine vaccination care as usual. After clinic staff explain the options - both vaccines on the same day at different injection sites, on different days, or waiting - parents freely choose, and the study records the choice. Families who take part receive short follow-up contacts about 1 week, 1 month, and 6 weeks after each vaccination to ask about fever, rash, or other health problems, complete a short satisfaction survey at 1 month, and are followed for 90 days through immunization records. Results will also be compared with de-identified immunization records of similar children from the same clinics before the service was introduced.
Conditions
- Hepatitis A Vaccine
- Varicella Immunisation
Interventions
Live Attenuated Varicella VaccineBiological
Live attenuated varicella vaccine (Oka strain), given as a single 0.5 mL subcutaneous dose according to the national immunization schedule and the vaccine label. In this non-interventional study the vaccine is administered as routine care; the study does not assign, modify, or delay any vaccination. This is the exposure of interest for the 0-42 day safety observation window, including delayed varicella-like rash.
Inactivated Hepatitis A VaccineBiological
Inactivated hepatitis A vaccine, given intramuscularly in the upper arm according to the national immunization schedule and the vaccine label. In this non-interventional study the vaccine is administered as routine care; the study does not assign, modify, or delay any vaccination. This is the exposure of interest for the 0-30 day safety observation window.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Acceptance rate of same-day co-administrationTime frame: Day 0 (at enrollment, i.e., the day of the vaccination decision)
- Completion rate of both vaccines within 90 daysTime frame: Through 90 days after screening
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Juye County Center for Disease Control and Prevention
Heze, Shandong, China
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.